tiprankstipranks
Trending News
More News >
Annovis Bio (ANVS)
NYSE:ANVS
US Market

Annovis Bio (ANVS) Income Statement

Compare
725 Followers

Annovis Bio Income Statement

Last quarter (Q4 2025), Annovis Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Annovis Bio's net income was $-9.83M. See Annovis Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Mar 23Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 29.70M$ 26.69M$ 45.03M$ 25.51M$ 14.54M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -29.70M$ -26.69M$ -45.03M$ -25.51M$ -14.50M
Operating Income
$ -29.70M$ -26.69M$ -45.03M$ -25.51M$ -14.54M
Other Income/Expenses
$ 841.06K$ 2.10M$ -11.17M$ 182.71K$ 50.09K
Pretax Income
$ -28.85M$ -24.59M$ -56.20M$ -25.33M$ -14.49M
Net Income
$ -28.85M$ -24.59M$ -56.20M$ -25.33M$ -14.49M
Per Share Metrics
Basic EPS
$ -1.40$ -2.02K$ -6.23$ -3.10$ -1.90
Diluted EPS
$ -1.40$ -2.01K$ -6.23$ -3.10$ -1.90
Weighted Average Shares Outstanding
20.55M 12.18M 9.02M 8.16M 7.63M
Weighted Average Shares Outstanding (Diluted)
20.55M 12.23M 9.02M 8.16M 7.63M
Currency in USD

Annovis Bio Earnings and Revenue History